Presentation is loading. Please wait.

Presentation is loading. Please wait.

The SyMPL approach applied to Staphylococcus aureus JE2.

Published byMerete Bak Modified over 5 years ago

Similar presentations

Presentation on theme: "The SyMPL approach applied to Staphylococcus aureus JE2."— Presentation transcript:

1 The SyMPL approach applied to Staphylococcus aureus JE2.
The SyMPL approach applied to Staphylococcus aureus JE2. (A) Propagation of minicircles (pEPSA5MC and pEPSA5SynJE2MC) lacking Dcm-methylated sites within SyMPL-producer strain E. coli JMC1. (B) Comparison of SyngenicDNA and pEPSA5-based SyMPL plasmid transformation efficiency (cfu/µg DNA) with JE2. (C) Secondary analysis of SyngenicDNA and pEPSA5-based SyMPL plasmid transformation efficiencies in cfu/pmol DNA. Data are means ± SEM from nine independent experiments (three biological replicates with three technical replicates each). Christopher D. Johnston et al. PNAS 2019;116:23: ©2019 by National Academy of Sciences

Download ppt "The SyMPL approach applied to Staphylococcus aureus JE2."

Similar presentations

Biology of genetic engineering Host cell types. Host cell types 1. Prokaryotic hosts; such as E. coli 2. Eukaryotic hosts; range from microbes, such as.

Biology of genetic engineering Host cell types. Host cell types 1. Prokaryotic hosts; such as E. coli 2. Eukaryotic hosts; range from microbes, such as.
Cloning Genes Gene cloning: amplifying a specific piece of DNA via a bacteria cell Cloning vector: a replicating DNA molecule attached with a foreign DNA.

Cloning Genes Gene cloning: amplifying a specific piece of DNA via a bacteria cell Cloning vector: a replicating DNA molecule attached with a foreign DNA.
Recombinant DNA What is the basis of recombinant DNA technology? How does one “clone” a gene? How are genetically modified organisms (GMOs) created? Illustration.

Recombinant DNA What is the basis of recombinant DNA technology? How does one “clone” a gene? How are genetically modified organisms (GMOs) created? Illustration.
 What is different between these 2 sequences? GGAATTCCTAGCAAT CCTTAAGGATCGTTA CTACGTGAGGAATTC GATGCACTCCTTAAG.

 What is different between these 2 sequences? GGAATTCCTAGCAAT CCTTAAGGATCGTTA CTACGTGAGGAATTC GATGCACTCCTTAAG.
Table 2. List of the test pathogenic bacteria

Table 2. List of the test pathogenic bacteria
Checklist for Site Reconnaissance (Sabatini et al_2002)

Checklist for Site Reconnaissance (Sabatini et al_2002)
Comparison (θ) of the mean dinucleotide variability distribution for (A) genes with MAE vs. Comparison (θ) of the mean dinucleotide variability distribution.

Comparison (θ) of the mean dinucleotide variability distribution for (A) genes with MAE vs. Comparison (θ) of the mean dinucleotide variability distribution.
Comparison (R) of the mean observed to expected dinucleotide distribution for (A) genes with MAE vs. Comparison (R) of the mean observed to expected dinucleotide.

Comparison (R) of the mean observed to expected dinucleotide distribution for (A) genes with MAE vs. Comparison (R) of the mean observed to expected dinucleotide.
Identification and characterization of a xap5 mutant in Chlamydomonas.

Identification and characterization of a xap5 mutant in Chlamydomonas.
FtsK‐independent dif recombination in the presence of HinXerC.

FtsK‐independent dif recombination in the presence of HinXerC.
Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25 cells. Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25.

Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25 cells. Expression of α5β1-integrin enhances EboV GP-mediated infection of GD25.
Schematic representation of possible effects of different factors on systemic resilience. Schematic representation of possible effects of different factors.

Schematic representation of possible effects of different factors on systemic resilience. Schematic representation of possible effects of different factors.
The evolution of WCI for biological specificity makes organisms more evolvable. The evolution of WCI for biological specificity makes organisms more evolvable.

The evolution of WCI for biological specificity makes organisms more evolvable. The evolution of WCI for biological specificity makes organisms more evolvable.
DHEA(S) and Allo activated transcription factors NF-κB and CREB in serum-deprived PC12 cells. DHEA(S) and Allo activated transcription factors NF-κB and.

DHEA(S) and Allo activated transcription factors NF-κB and CREB in serum-deprived PC12 cells. DHEA(S) and Allo activated transcription factors NF-κB and.
Pretreatment of VSV-GPΔ to form VSV-GP19K rescues infection in the α5β1-integrin-negative CHO cells. Pretreatment of VSV-GPΔ to form VSV-GP19K rescues.

Pretreatment of VSV-GPΔ to form VSV-GP19K rescues infection in the α5β1-integrin-negative CHO cells. Pretreatment of VSV-GPΔ to form VSV-GP19K rescues.
RGFP-966 decreases HDAC3 activity and is not cytotoxic.

RGFP-966 decreases HDAC3 activity and is not cytotoxic.
Variance priming for spatially nonoverlapping prime–target pairs.

Variance priming for spatially nonoverlapping prime–target pairs.
Dark blue E. coli had lower growth rate and yield in monoculture but grew faster in coculture with S. enterica. Dark blue E. coli had lower growth rate.

Dark blue E. coli had lower growth rate and yield in monoculture but grew faster in coculture with S. enterica. Dark blue E. coli had lower growth rate.
WCI evolve as organisms become more complex.

WCI evolve as organisms become more complex.
Patients with SLE have elevated ERV expression.

Patients with SLE have elevated ERV expression.

Similar presentations

Ads by Google